Lymphatic Education
& Research Network

Other Grants & Awards Programs

• Online Partnership to Accelerate Research

  OnPAR (Online Partnership to Accelerate Research) is a matchmaking platform where applicants and non-government funders come together.  Leidos Health’s Life Sciences has partnered with NIH and other funding organizations to accelerate the biomedical research and development enterprise by matching high-scoring unfunded applications with private biomedical foundations and/or industries seeking to fund promising research via OnPAR (e.g., for NIH these would be applications within the 30th percentile but are beyond the funding cutoff).

  OnPAR has member organizations and matches the unfunded applications with the funding organization.  For more information, please visit https://onpar.leidosweb.com/.

  Learn More >
• Lymphatics in Health and Disease in the Digestive System (R01-Clinical Trials Not Allowed)

  Funding Opportunity Purpose: The purpose of this FOA (#RFA-DK-17-016) is to invite applications that investigate aspects of lymphatic vessel physiology, development and pathophysiology related to health and diseases of the digestive system. Studies to understand the factors that control local lymphatic vessel functional anatomy and physiology and development during health or disease in this system and its organs, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest. Please note, however, that studies with the major focus on immune mechanisms, role of lymphatics in cancer metastasis and study of lymphatic vessels in organs other than those from the digestive system will not be considered responsive.

  NIDDK intends to commit $1,000,000 in FY 2018 to fund up to 3 R01 awards. Application budgets are limited to $499,999 direct costs per year exclusive of subcontracts F&A. The maximum project period is 5 years. Letter of intent are due January 2nd, 2018. Application due date is February 2, 2018 by 5:00 PM local time of applicant organization.

  For application instructions and more information, please visit https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-016.html.

  Open Date (Earliest Submission Date) - January 2, 2018
  Letter of Intent Due Date - January 2, 2018
  Application Due Date - February 2, 2018 (by 5:00 PM local time of applicant organization)

  Learn More >
• Lymphatics in Health and Disease in the Digestive System, Kidney, and Urinary Tract (R01)

  Funding Opportunity Purpose:  This FOA is to encourage Research Project Grant (R01) applications for research into aspects of lymphatic vessel physiology, development and pathophysiology related to health and diseases of the digestive system, kidney, and urinary tract organs. However, studies with the major focus on immune mechanisms are not encouraged. Studies to understand the factors that control local lymphatic vessel functional anatomy and physiology and development during health or disease in these organs/systems, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest.

  For application instructions, please visit https://grants.nih.gov/grants/guide/pa-files/PAR-15-306.html.

  Open Date:  September 5, 2015
  Application Due Date:  September 8, 2018

  Learn More >
• The Lipedema Foundation Welcomes Letter of Intent Submissions

  The Lipedema Foundation (LF) announces a call for Letters of Intent (LOI), soliciting high-impact and exploratory research from scientists and clinicians around the world. The LOI calls for ideas that have the potential to define, diagnose and develop treatments for lipedema. They welcome LOIs for Trainee and Postdoctoral fellowships, one year Proof-of-Concept Awards, and multi-year Collaborative Awards.
  
  The deadline for LOI’s is May 15, 2017.

  For more information and LOI submission, please visit https://www.lipedema.org/grant-submission/.

  Learn More >
• Patient-Centered Outcomes Research Institute

  PCORI funds research into conditions that affect large numbers of people across a range of populations; conditions that place a heavy burden on individuals, families, specific populations, and society; and rare diseases, which are difficult to study. PCORI funds research through organizations and not individuals. Find out more at www.pcori.org/content/what-who-we-fund.

  Learn More >